Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6344.0000 -48.50 (-0.76%)
NSE Jan 01, 2026 15:31 PM
Volume: 146.5K
 

6344.00
-0.76%
Phillip Capital
Divi's Q1FY16 operating performance was just in line with our estimates with 26%/32% growth in sales/adjusted profit. Going ahead, the management expects to maintainsteadygrowthledbyprocessimprovementintheexistinggenericmolecules...
Divi's Laboratories Ltd. is trading above its 200 day SMA of 6308.4
More from Divi's Laboratories Ltd.
Recommended